PhD, Director of Research, Reproductive Genetics Institute
Preimplantation aneuploidy testing has become an established tool for preselection of oocytes and embryos with the highest developmental potential. The technique has evolved into 24 chromosome aneuploidy testing, using microarray analysis and most recently also next generation sequencing technology (NGS).
Anver Kuliev received his PhD in Clinical Cytogenetics in 1969. From 1979 he was head of the World Health Organization (WHO)’s Hereditary Diseases Program in Geneva, where he developed the community-based programs for prevention of genetic disorders and early approaches for prenatal diagnosis. He moved to Reproductive Genetics Institute, Chicago, in 1990, where he heads the WHO Collaborating Center for Prevention of Genetic Disorders, and scientific research in prenatal and preimplantation genetics. He is an author of 200 papers, including 11 books in the above areas, including 5 books in the field of Preimplantation Genetics.
His special interests include Prenatal and Preimplantation Genetics and Community Genetics.
Santiago Munné is the Founder and Director of Reprogenetics. He gained his Ph.D. in Genetics from the University of Pittsburgh and in 1991, joined Dr. Jacques Cohen at the Cornell University Medical College located in New York City. It was at Cornell that he developed the first Preimplantation Genetic Diagnosis test to detect embryonic numerical chromosome abnormalities. Dr. Munné became the Director of Preimplantation Genetic Diagnosis at The Institute for Reproductive Medicine and Science of Saint Barnabas in 1995. Dr. Munné’s research interests include developing new PGD techniques, understanding the impact of chromosome abnormalities in human reproduction, as well as the production and study of genetically defined stem cells.
Anver Kuliev, director of research at the Reproductive Genetics Institute, recalls the first conference of the International Working Group on Preimplantation Genetics and the early successes of the technique.